Get started
Organogenesis Holdings Inc.Organogenesis Holdings Inc.Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ORGO chart


Full chart

ORGO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪539.02 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
758.93
Basic EPS (TTM)
0.01 USD
Net income (FY)
‪861.00 K‬ USD
Revenue (FY)
‪482.04 M‬ USD
Shares float
‪64.38 M‬
Beta (1Y)
1.56

Employees


Employees (FY)
869
Change (1Y)
+7 +0.81%
Revenue / Employee (1Y)
‪554.71 K‬ USD
Net income / Employee (1Y)
990.79 USD

About Organogenesis Holdings Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Gary S. Gillheeney
Website
organogenesis.com
Headquarters
Canton
Founded
1985
FIGI
BBG00FGGD295
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ORGO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ORGO.

Frequently Asked Questions


The current price of ORGO is 4.22 USD — it has decreased by −0.71% in the past 24 hours. Watch Organogenesis Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Organogenesis Holdings Inc. stocks are traded under the ticker ORGO.
ORGO stock has risen by 8.21% compared to the previous week, the month change is a −14.75% fall, over the last year Organogenesis Holdings Inc. has showed a 46.53% increase.
We've gathered analysts' opinions on Organogenesis Holdings Inc. future price: according to them, ORGO price has a max estimate of 7.00 USD and a min estimate of 5.00 USD. Watch ORGO chart and read a more detailed Organogenesis Holdings Inc. stock forecast: see what analysts think of Organogenesis Holdings Inc. and suggest that you do with its stocks.
ORGO reached its all-time high on Jan 9, 2019 with the price of 310.90 USD, and its all-time low was 1.80 USD and was reached on Apr 26, 2023. View more price dynamics on ORGO chart.
See other stocks reaching their highest and lowest prices.
ORGO stock is 4.99% volatile and has beta coefficient of 1.56. Track Organogenesis Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is Organogenesis Holdings Inc. there?
Today Organogenesis Holdings Inc. has the market capitalization of ‪535.21 M‬, it has increased by 5.88% over the last week.
Yes, you can track Organogenesis Holdings Inc. financials in yearly and quarterly reports right on TradingView.
Organogenesis Holdings Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ORGO earnings for the last quarter are 0.04 USD per share, whereas the estimation was −0.011 USD resulting in a 451.65% surprise. The estimated earnings for the next quarter are −0.037 USD per share. See more details about Organogenesis Holdings Inc. earnings.
Organogenesis Holdings Inc. revenue for the last quarter amounts to ‪126.66 M‬ USD, despite the estimated figure of ‪109.61 M‬ USD. In the next quarter, revenue is expected to reach ‪90.77 M‬ USD.
ORGO net income for the last quarter is ‪7.67 M‬ USD, while the quarter before that showed ‪12.33 M‬ USD of net income which accounts for −37.77% change. Track more Organogenesis Holdings Inc. financial stats to get the full picture.
No, ORGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 869 employees. See our rating of the largest employees — is Organogenesis Holdings Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Organogenesis Holdings Inc. EBITDA is ‪46.89 M‬ USD, and current EBITDA margin is 9.77%. See more stats in Organogenesis Holdings Inc. financial statements.
Like other stocks, ORGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Organogenesis Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Organogenesis Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Organogenesis Holdings Inc. stock shows the buy signal. See more of Organogenesis Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.